# IV Lidocaine in Pediatric AIS

> **NCT03893318** · PHASE4 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 15 (actual)

## Conditions studied

- Systemic Lidocaine Improves Pain Control After Surgery by Attenuating the Systemic Inflammatory Response to Surgery

## Interventions

- **DRUG:** IV lidocaine
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03893318
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-30
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** PI moved to a different institution.
- **Last updated:** 2025-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03893318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03893318, "IV Lidocaine in Pediatric AIS". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03893318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*